Webcast/CME - Biologics and Infections: Common and Rare

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Infectious Other

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Infectious Other

Recent news - Infectious Other

	Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
	Effect of High Perioperative Oxygen Fraction on Surgical Site Infection and Pulmonary Complications After Abdominal Surgery: The PROXI Randomized Clinical Trial - (JAMA)
	A randomized trial of doxycycline for Mansonella perstans infection - (N Engl J Med)
	FDA Approves Ustekinumab for Moderate to Severe Psoriasis - (DGNews)
	Once-Daily Tablet Effective in Treating Oral Yeast Infection in Patients With HIV: Presented at ICAAC - (DGDispatch)

Recent cases - Infectious Other

	Diphyllobothriasis
	Severe Anemia From Bedbugs
	Infestation by Norwegian scabies
	Late Presentation of Cutaneous Larva Migrans: A Case Report
	A Patient with Prickling Boils

personal edition > infectious other > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Biologics and Infections: Common and Rare

Presented by:	The Cleveland Clinic Foundation Center for Continuing Education
Lecturer	Leonard Calabrese, DO, John Cush, MD, Jonathan Kay, MD, R. John Looney, MD, Eamonn Molloy, MD, Christopher T. Ritchlin, MD, E. William St. Clair, MD and Nizar N. Zein, MD
Approximate duration:	2.5 hrs.
Summary points:	In this audiovisual CME programme, a panel of rheumatology experts discuss findings from the Biologics Therapies Summitt III, including recommendations for monitoring immunocompetency in clinical trials of immunosuppressive therapies, and the risks for serious infections with biologic use.
Accreditation:	The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits. Expiration Date: September 4, 2011.
Other:

Additional Information